IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 42 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $11,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,267,500 | $4,766,000 | 3.18% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 622,744 | $2,342,000 | 0.82% |
| MARATHON ASSET MANAGEMENT LP | 833,333 | $3,133,000 | 0.17% |
| BARD ASSOCIATES INC | 65,500 | $246,000 | 0.13% |
| CORRADO ADVISORS, LLC | 31,107 | $117,000 | 0.08% |
| MARATHON CAPITAL MANAGEMENT | 25,000 | $94,000 | 0.05% |
| Granite Investment Partners, LLC | 155,190 | $584,000 | 0.05% |
| BlackRock Investment Management, LLC | 1,966 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 548 | $2,000 | 0.00% |
| Creative Planning | 750 | $3,000 | 0.00% |